It is not a dosing recommendation or a published clinical protocol
The co-factor stack compounds this: ALA: Regenerates oxidised glutathione back to active form extends effective activity NAC: Provides cysteine, the rate-limiting precursor for endogenous glutathione synthesis Astaxanthin: UV-protective carotenoid prevents oxidative damage that triggers melanin production Richie et al
Everyone is unique and there are multiple factors that affect how quickly you will start seeing results with your treatments
In September 2023 the FDA placed BPC-157 in Category 2 of its 503A interim bulk-substances policy, citing immunogenicity and peptide-characterization concerns, effectively excluding it from the 503A compounding bulk-substances list
BPC-157 : Gly- Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val : C 62 H 98 N 15 O 22 : 1419.556 g/mol PubChem CID : 108101 BPC-157 BPC - - , , ,
Seniors often see dramatic improvements because glutathione production naturally declines with age